New York State Common Retirement Fund
TCRT icon

New York State Common Retirement Fund’s Alaunos Therapeutics TCRT Stock Holding History

New York State Common Retirement Fund’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11
Closed -$2K – 3440
2022
Q2 		$2K Sell
11
-909
-99% -$86.9K ﹤0.01% 3295
2022
Q1 		$90K Hold
920
– – ﹤0.01% 3045
2021
Q4 		$150K Sell
920
-1
-0.1% -$220 ﹤0.01% 2972
2021
Q3 		$252K Sell
921
-261
-22% -$79.8K ﹤0.01% 2822
2021
Q2 		$468K Buy
1,182
+12
+1% +$5.6K ﹤0.01% 2628
2021
Q1 		$632K Buy
1,170
+101
+9% +$62.9K ﹤0.01% 2340
2020
Q4 		$404K Sell
1,069
-232
-18% -$92.2K ﹤0.01% 2450
2020
Q3 		$492K Hold
1,301
– – ﹤0.01% 2222
2020
Q2 		$640K Buy
1,301
+354
+37% +$158K ﹤0.01% 2092
2020
Q1 		$348K Hold
947
– – ﹤0.01% 2211
2019
Q4 		$671K Sell
947
-156
-14% -$107K ﹤0.01% 2142
2019
Q3 		$708K Buy
1,103
+8
+0.7% +$6.35K ﹤0.01% 2160
2019
Q2 		$958K Buy
1,095
+253
+30% +$174K ﹤0.01% 2041
2019
Q1 		$486K Hold
842
– – ﹤0.01% 2325
2018
Q4 		$236K Hold
842
– – ﹤0.01% 2638
2018
Q3 		$404K Hold
842
– – ﹤0.01% 2510
2018
Q2 		$381K Hold
842
– – ﹤0.01% 2575
2018
Q1 		$495K Hold
842
– – ﹤0.01% 2358
2017
Q4 		$523K Hold
842
– – ﹤0.01% 2334
2017
Q3 		$775K Sell
842
-110
-12% -$97.7K ﹤0.01% 2138
2017
Q2 		$888K Hold
952
– – ﹤0.01% 2112
2017
Q1 		$905K Buy
952
+98
+11% +$91.3K ﹤0.01% 2080
2016
Q4 		$685K Buy
854
+119
+16% +$107K ﹤0.01% 2225
2016
Q3 		$621K Hold
735
– – ﹤0.01% 2207
2016
Q2 		$606K Hold
735
– – ﹤0.01% 2203
2016
Q1 		$818K Hold
735
– – ﹤0.01% 2055
2015
Q4 		$917K Hold
735
– – ﹤0.01% 2035
2015
Q3 		$994K Sell
735
-18
-2% -$29.7K ﹤0.01% 1953
2015
Q2 		$1.35M Buy
+753
New +$1.17M ﹤0.01% 2032

Other funds holding TCRT

MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Discovery Capital Management
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

New York State Common Retirement Fund's TCRT Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Alaunos Therapeutics (TCRT) in Q3 2022, closing a stake of 11 shares — an estimated $2K sold.

New York State Common Retirement Fund first reported a position in TCRT in Q2 2015 and held it in 29 quarters. The position peaked at $1.35M in Q2 2015. 125 funds tracked by Wall St. Rank hold TCRT as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Alaunos Therapeutics position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 11 Alaunos Therapeutics shares in Q3 2022, an estimated $2K.
  • New York State Common Retirement Fund first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 29 quarters.
  • New York State Common Retirement Fund's Alaunos Therapeutics position peaked at $1.35M in Q2 2015.
  • 125 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.